EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Association between Immune Checkpoint Inhibitors and Atherosclerotic Cardiovascular Disease Risk: Another Brick in the Wall

Linda Piras iD, Michela Zuccanti, Paola Russo, Francesca Riccio, Antonio Agresti iD, Camilla Lustri, Domenico Dardani, Armando Ferrera iD, Vincenzo Fiorentini, Giuliano Tocci iD, Giacomo Tini Melato, Massimo Volpe und 2 weitere

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25052502 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Linda Piras und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Molecular Medicine, Sapienza University of Rome, 00189 Rome, Italy. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Neoplasms, Myocarditis, Heart Diseases. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 111 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of Health [Ricerca corrente].

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In recent years, immune checkpoint inhibitors have significantly changed the field of oncology, emerging as first-line treatment, either alone or in combination with other regimens, for numerous malignancies, improving overall survival and progression-free survival in these patients. However, immune checkpoint inhibitors might also cause severe or fatal immune-related adverse events, including adverse cardiovascular events. Initially, myocarditis was recognized as the main immune checkpoint inhibitor-related cardiac event, but our knowledge of other potential immune-related cardiovascular adverse events continues to broaden. Recently, preclinical and clinical data seem to support an association between immune checkpoint inhibitors and accelerated atherosclerosis as well as atherosclerotic cardiovascular events such as cardiac ischemic disease, stroke, and peripheral artery disease. In this review, by offering a comprehensive overview of the pivotal role of inflammation in atherosclerosis, we focus on the potential molecular pathways underlying the effects of immune checkpoint inhibitors on cardiovascular diseases. Moreover, we provide an overview of therapeutic strategies for cancer patients undergoing immunotherapy to prevent the development of cardiovascular diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesNeoplasmsMyocarditisHeart DiseasesAtherosclerosisHumansImmune Checkpoint InhibitorsCardiotoxicityImmunotherapy

Stichwörter der Autor:innen

atherosclerosisatherosclerotic cardiovascular eventscancercardiac eventcardiotoxicityimmune checkpoint inhibitorsimmunotherapyinflammation

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Department of Clinical and Molecular Medicine, Sapienza University of Rome, 00189 Rome, Italy.
  • IRCCS San Raffaele, 00166 Rome, Italy.

ORCID-Profile: Linda Piras, Antonio Agresti, Armando Ferrera, Giuliano Tocci, Allegra Battistoni

Förderung

  • Italian Ministry of Health [Ricerca corrente]

Zitieren

APA

Piras, L., Zuccanti, M., Russo, P., Riccio, F., Agresti, A., Lustri, C., Dardani, D., Ferrera, A., Fiorentini, V., Tocci, G., Tini Melato, G., Volpe, M., Barbato, E., & Battistoni, A. (2024). Association between Immune Checkpoint Inhibitors and Atherosclerotic Cardiovascular Disease Risk: Another Brick in the Wall. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25052502

Vancouver

Piras L, Zuccanti M, Russo P, Riccio F, Agresti A, Lustri C, et al. Association between Immune Checkpoint Inhibitors and Atherosclerotic Cardiovascular Disease Risk: Another Brick in the Wall. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25052502

BibTeX
@article{Piras2024,
  author = {Piras, Linda and Zuccanti, Michela and Russo, Paola and Riccio, Francesca and Agresti, Antonio and Lustri, Camilla and Dardani, Domenico and Ferrera, Armando and Fiorentini, Vincenzo and Tocci, Giuliano and Tini Melato, Giacomo and Volpe, Massimo and Barbato, Emanuele and Battistoni, Allegra},
  title = {Association between Immune Checkpoint Inhibitors and Atherosclerotic Cardiovascular Disease Risk: Another Brick in the Wall},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25052502}
}
Kostenlos starten →